A study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A or B

Trial Identifier: EFC17905
Sponsor: Sanofi
Start Date: December 2025
Primary Completion Date: August 2029
Study Completion Date: December 2031
Condition: Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BELGIUM Brussels, BELGIUM, 1020
BELGIUM Brussels, BELGIUM, 1200
BRAZIL, São Paulo Ribeirão Preto, São Paulo, BRAZIL, 14049-900
BRAZIL, São Paulo São Paulo, BRAZIL, 05403-000
CANADA, Quebec Montreal, Quebec, CANADA, H3T 1C5
INDIA Mumbai, INDIA, 400022
INDIA Pune, INDIA, 411004
ITALY, Firenze Florence, Firenze, ITALY, 50134
ITALY, Milano Milan, Milano, ITALY, 20122
ITALY, Milano Rozzano, Milano, ITALY, 20089
POLAND, Dolnoslaskie Wroclaw, Dolnoslaskie, POLAND, 50-556
ROMANIA Iasi, ROMANIA, 700309
ROMANIA Timișoara, ROMANIA, 300011
SPAIN, Barcelona [Barcelona] Esplugues De Llobregat, Barcelona [Barcelona], SPAIN, 08950
SPAIN, Madrid Madrid, SPAIN, 28046
SPAIN, Zaragoza Zaragoza, SPAIN, 50009
TAIWAN, PROVINCE OF CHINA Taichung, TAIWAN, PROVINCE OF CHINA, 402
TAIWAN, PROVINCE OF CHINA Taipei City, TAIWAN, PROVINCE OF CHINA, 100
Turkey Istanbul, Turkey, 34093
Turkey Izmir, Turkey, 35100
UNITED STATES, California Los Angeles, California, UNITED STATES, 90007
UNITED STATES, California Orange, California, UNITED STATES, 92868
UNITED STATES, Nevada Las Vegas, Nevada, UNITED STATES, 89147
UNITED STATES, New Jersey Hackensack, New Jersey, UNITED STATES, 07601